Biopharmaceutical firm Hutchmed China Ltd., backed by billionaire Li Ka-shing, has agreed to sell stakes in a health unit for about $608 million as the group seeks to generate capital and focus on its core businesses.
Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million
Estimated read time
1 min read
You May Also Like
BlackRock: US Stocks May See Periods of ‘Choppy Trading’
January 6, 2025
Investment banks prepare for 2025 crunch
January 6, 2025
+ There are no comments
Add yours